MORGAN STANLEY PLC/CALL/ZOETIS/180/0.1/17.01.25 Share Price

Warrant

DE000MB35444

Real-time Bid/Ask 15:09:42 01/07/2024 BST
1.42 EUR / 1.44 EUR -2.05% Intraday chart for MORGAN STANLEY PLC/CALL/ZOETIS/180/0.1/17.01.25
Current month+21.67%
1 month+11.45%
Date Price Change
01/07/24 1.35 -7.53%
28/06/24 1.46 -2.67%
27/06/24 1.5 +20.00%
26/06/24 1.25 +5.93%
25/06/24 1.18 -13.87%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 09:03 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ZOETIS INC.
Issuer Morgan Stanley
WKN MB3544
ISINDE000MB35444
Date issued 02/02/2023
Strike 180 $
Maturity 17/01/2025 (200 Days)
Parity 10 : 1
Emission price 2.71
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 4.05
Lowest since issue 0.56
Delta0.52x
Omega 6.096
Premium12.39x
Gearing11.68x
Moneyness 0.9631
Difference Strike 5.47 $
Difference Strike %+3.04%
Spread 0.04
Spread %2.86%
Theoretical value 1.420
Implied Volatility 30.59 %
Total Loss Probability 55.38 %
Intrinsic value 0.000000
Present value 1.420
Break even 195.27 €
Theta-0.03x
Vega0.05x
Rho0.04x

Company Profile

Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Sector
-
More about the company

Ratings for Zoetis Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Zoetis Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
173.4 USD
Average target price
210.2 USD
Spread / Average Target
+21.22%
Consensus